Review



human breast carcinoma mcf 7 cells  (ATCC)


Bioz Verified Symbol ATCC is a verified supplier
Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 99
      Buy from Supplier

    Structured Review

    ATCC human breast carcinoma mcf 7 cells
    Human Breast Carcinoma Mcf 7 Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 35046 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+breast+carcinoma+mcf+7+cells/MCF7/pmc13179769-74-5-16
    Average 99 stars, based on 35046 article reviews
    human breast carcinoma mcf 7 cells - by Bioz Stars, 2026-10
    99/100 stars

    Images

    Related Articles

    other:

    Article Title: Hydrophobic CPP/HDO conjugates: a new frontier in oligonucleotide-warheaded PROTAC delivery
    Article Snippet: Human breast carcinoma MCF-7 cells were purchased from ATCC (Manassas, VA), and maintained in RPMI 1640 medium (Sigma-Aldrich, St. Louis, MO, USA) containing 10% fetal bovine serum (FBS) and 100 U mL −1 penicillin, 100 μg mL −1 streptomycin (NACALAI TESQUE).

    Article Title: Development of DNA Aptamer-Based PROTACs That Degrade the Estrogen Receptor.
    Article Snippet: Human breast carcinoma MCF-7 cells were purchased from ATCC (Manassas, VA), and maintained in RPMI 1640 medium (Sigma-Aldrich, St. Louis, MO, USA) containing 10% fetal bovine serum (FBS) and 100 μg/mL Kanamycin (Sigma-Aldrich).

    Article Title: Back to Nature: Development and Optimization of Bioinspired Nanocarriers for Potential Breast Cancer Treatment
    Article Snippet: Human breast carcinoma (MCF-7) cells were obtained from the American Type Culture Collection (ATCC, Rockville, MD, USA).

    Cell Culture:

    Article Title: GBVAM as a Novel NHE1 Inhibitor Alleviates Doxorubicin-Induced Cardiotoxicity via PI3K/Akt/mTOR Pathway
    Article Snippet: .. The rat cardiomyocytes H9c2 cells, human breast carcinoma MCF-7 cells and mouse breast carcinoma 4T1 cells (ATCC, America) were cultured with DMEM or RPMI 1640 (C11995500BT or C11875500BT, Gibco) added with 10% FBS (FSP500, ExCell bio) and 1% penicillin-streptomycin ( PB180120 , Solarbio). ..

    Article Title: Exploring the Effect of Drug Loading on the Biological Fate of Polymer-Coated Solid Nanoparticles
    Article Snippet: Polymer-coated inorganic nanoparticles (NPs) have attracted great attention in drug delivery fields due to their unique magnetic, optical, and thermal properties.. Recent studies have shown that the surface physicochemical properties of these NPs, including the size, shape, shell hydration, protein corona, and so forth, affect their biological fate.. However, there has been less attention on the effect of the drug loading amount on the biological activity of inorganic NPs.

    Multiple Displacement Amplification:

    Article Title: Castalin Induces ROS Production, Leading to DNA Damage and Increasing the Activity of CHK1 Inhibitor in Cancer Cell Lines
    Article Snippet: .. Cervix adenocarcinoma (HeLa), human triple-negative breast cancer (TNBC) model (MDA-MB-231), and pleural effusion of hormone-dependent human breast carcinoma (MCF-7) cells were obtained from the American Type Culture Collection (ATCC). .. HeLa and MDA-MB 231 were cultured in Roswell Park Memorial Institute (RPMI) 1640 medium (Thermo Fisher Scientific, Waltham, MA, USA).

    Modification:

    Article Title: PSMAx-Guided PROTAC Degraders for Tumor-Specific Protein Degradation in Prostate Cancer
    Article Snippet: LNCaP cells and 22Rv1 cells (Human prostate cancer cells) were purchased from Procell Life Science & Technology Co., Ltd. and cultured in RPMI1640 (Procell, PM150110) with 10% fetal bovine serum (Gibco, 51985-034) and 1% penicillin streptomycin. .. Vertebral Cancer of the Prostate (VCaP) cells, Human breast carcinoma (MCF-7) cells and Human embryonic kidney 293T (HEK-293T) cells were purchased from ATCC and maintained in Dulbecco’s modified Eagle’s medium (DMEM) containing 10% FBS and 1% penicillin streptomycin. ..



    Similar Products

    human breast carcinoma mcf 7 cells  (ATCC)
    99
    ATCC human breast carcinoma mcf 7 cells
    Human Breast Carcinoma Mcf 7 Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+breast+carcinoma+mcf+7+cells/MCF7/pmc13179769-74-5-16
    Average 99 stars, based on 1 article reviews
    human breast carcinoma mcf 7 cells - by Bioz Stars, 2026-10
    99/100 stars
    		  Buy from Supplier
    human breast carcinoma cells mcf 7  (ATCC)
    99
    ATCC human breast carcinoma cells mcf 7
    In vitro biocompatibility evaluation of probe 1 after incubation with MCF-10A cells (A) <t>and</t> <t>MCF-7</t> (B) cells.
    Human Breast Carcinoma Cells Mcf 7, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+breast+carcinoma+mcf+7+cells/MCF7/pmc12983222-61-1-6
    Average 99 stars, based on 1 article reviews
    human breast carcinoma cells mcf 7 - by Bioz Stars, 2026-10
    99/100 stars
    		  Buy from Supplier
    human breast carcinoma cell line mcf  (ATCC)
    99
    ATCC human breast carcinoma cell line mcf
    In vitro biocompatibility evaluation of probe 1 after incubation with MCF-10A cells (A) <t>and</t> <t>MCF-7</t> (B) cells.
    Human Breast Carcinoma Cell Line Mcf, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+breast+carcinoma+mcf+7+cells/MCF7/10__1016_slash_j__eujim__2026__102629-80-1-14
    Average 99 stars, based on 1 article reviews
    human breast carcinoma cell line mcf - by Bioz Stars, 2026-10
    99/100 stars
    		  Buy from Supplier
    human breast carcinoma cells mcf 7  (Procell Inc)
    86
    Procell Inc human breast carcinoma cells mcf 7
    A) Schematic diagram of the experimental design for assessing the motility of Raw264.7 cells after metabolic intervention or hypoxia induction in vitro using living cell imaging technology. B) Representative images and migration tracks of Raw264.7 cells under different treatments. C) Average intracellular ATP content ( n = 3), and D) cell migration velocity under different treatment conditions ( n = 5). E) CLSM images of hypoxia levels in 4T1 <t>and</t> <t>MCF‐7</t> cells marked with hypoxia probes. F) CLSM images of HIF‐1α expression in 4T1 and MCF‐7 cells labeled by immunofluorescence staining. G,H) Semi‐quantitative analysis of hypoxia levels and HIF‐1α expression by fluorescence intensity ( n = 3). Data are presented as mean ± SD. Statistical significance was calculated via one‐way ANOVA with Tukey’ post hoc test. (* p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001).
    Human Breast Carcinoma Cells Mcf 7, supplied by Procell Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+breast+carcinoma+mcf+7+cells/carcinoma+cells/pmc12850126-267-7-24
    Average 86 stars, based on 1 article reviews
    human breast carcinoma cells mcf 7 - by Bioz Stars, 2026-10
    86/100 stars
    		  Buy from Supplier
    human breast carcinoma cell line mcf 7  (ATCC)
    99
    ATCC human breast carcinoma cell line mcf 7
    A) Schematic diagram of the experimental design for assessing the motility of Raw264.7 cells after metabolic intervention or hypoxia induction in vitro using living cell imaging technology. B) Representative images and migration tracks of Raw264.7 cells under different treatments. C) Average intracellular ATP content ( n = 3), and D) cell migration velocity under different treatment conditions ( n = 5). E) CLSM images of hypoxia levels in 4T1 <t>and</t> <t>MCF‐7</t> cells marked with hypoxia probes. F) CLSM images of HIF‐1α expression in 4T1 and MCF‐7 cells labeled by immunofluorescence staining. G,H) Semi‐quantitative analysis of hypoxia levels and HIF‐1α expression by fluorescence intensity ( n = 3). Data are presented as mean ± SD. Statistical significance was calculated via one‐way ANOVA with Tukey’ post hoc test. (* p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001).
    Human Breast Carcinoma Cell Line Mcf 7, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+breast+carcinoma+mcf+7+cells/MCF7/pmc12698734-34-53-65
    Average 99 stars, based on 1 article reviews
    human breast carcinoma cell line mcf 7 - by Bioz Stars, 2026-10
    99/100 stars
    		  Buy from Supplier
    human breast carcinoma mcf 7 cell line  (ATCC)
    99
    ATCC human breast carcinoma mcf 7 cell line
    A) Schematic diagram of the experimental design for assessing the motility of Raw264.7 cells after metabolic intervention or hypoxia induction in vitro using living cell imaging technology. B) Representative images and migration tracks of Raw264.7 cells under different treatments. C) Average intracellular ATP content ( n = 3), and D) cell migration velocity under different treatment conditions ( n = 5). E) CLSM images of hypoxia levels in 4T1 <t>and</t> <t>MCF‐7</t> cells marked with hypoxia probes. F) CLSM images of HIF‐1α expression in 4T1 and MCF‐7 cells labeled by immunofluorescence staining. G,H) Semi‐quantitative analysis of hypoxia levels and HIF‐1α expression by fluorescence intensity ( n = 3). Data are presented as mean ± SD. Statistical significance was calculated via one‐way ANOVA with Tukey’ post hoc test. (* p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001).
    Human Breast Carcinoma Mcf 7 Cell Line, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+breast+carcinoma+mcf+7+cells/MCF7/pmc12424428-235-1-14
    Average 99 stars, based on 1 article reviews
    human breast carcinoma mcf 7 cell line - by Bioz Stars, 2026-10
    99/100 stars
    		  Buy from Supplier

    Image Search Results


    In vitro biocompatibility evaluation of probe 1 after incubation with MCF-10A cells (A) and MCF-7 (B) cells.

    Journal: RSC Advances

    Article Title: A new indoloquinoline-based fluorescence probe for imaging of hydrazine in vitro and in vivo

    doi: 10.1039/d5ra08919k

    Figure Lengend Snippet: In vitro biocompatibility evaluation of probe 1 after incubation with MCF-10A cells (A) and MCF-7 (B) cells.

    Article Snippet: The human breast carcinoma cells MCF-7 (ATCC, USA), and normal breast epithelial cells MCF-10A (CCTCC, China), were cultured under controlled conditions.

    Techniques: In Vitro, Incubation

    Fluorescence imaging of probe 1 in MCF-7 tumor-bearing mice at various intervals pre- and post-injection.

    Journal: RSC Advances

    Article Title: A new indoloquinoline-based fluorescence probe for imaging of hydrazine in vitro and in vivo

    doi: 10.1039/d5ra08919k

    Figure Lengend Snippet: Fluorescence imaging of probe 1 in MCF-7 tumor-bearing mice at various intervals pre- and post-injection.

    Article Snippet: The human breast carcinoma cells MCF-7 (ATCC, USA), and normal breast epithelial cells MCF-10A (CCTCC, China), were cultured under controlled conditions.

    Techniques: Fluorescence, Imaging, Injection

    A) Schematic diagram of the experimental design for assessing the motility of Raw264.7 cells after metabolic intervention or hypoxia induction in vitro using living cell imaging technology. B) Representative images and migration tracks of Raw264.7 cells under different treatments. C) Average intracellular ATP content ( n = 3), and D) cell migration velocity under different treatment conditions ( n = 5). E) CLSM images of hypoxia levels in 4T1 and MCF‐7 cells marked with hypoxia probes. F) CLSM images of HIF‐1α expression in 4T1 and MCF‐7 cells labeled by immunofluorescence staining. G,H) Semi‐quantitative analysis of hypoxia levels and HIF‐1α expression by fluorescence intensity ( n = 3). Data are presented as mean ± SD. Statistical significance was calculated via one‐way ANOVA with Tukey’ post hoc test. (* p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001).

    Journal: Advanced Science

    Article Title: Photo‐Empowered Macrophage‐Based Drug Delivery System Overcomes Motility Suppression and Significantly Enhances Deep Tumor Drug Delivery

    doi: 10.1002/advs.202515349

    Figure Lengend Snippet: A) Schematic diagram of the experimental design for assessing the motility of Raw264.7 cells after metabolic intervention or hypoxia induction in vitro using living cell imaging technology. B) Representative images and migration tracks of Raw264.7 cells under different treatments. C) Average intracellular ATP content ( n = 3), and D) cell migration velocity under different treatment conditions ( n = 5). E) CLSM images of hypoxia levels in 4T1 and MCF‐7 cells marked with hypoxia probes. F) CLSM images of HIF‐1α expression in 4T1 and MCF‐7 cells labeled by immunofluorescence staining. G,H) Semi‐quantitative analysis of hypoxia levels and HIF‐1α expression by fluorescence intensity ( n = 3). Data are presented as mean ± SD. Statistical significance was calculated via one‐way ANOVA with Tukey’ post hoc test. (* p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001).

    Article Snippet: Mouse breast carcinoma cells 4T1 (RRID: CVCL_0125), human breast carcinoma cells MCF‐7 (RRID: CVCL_0031), and mouse monocyte‐macrophage cells RAW264.7 (RRID: CVCL_0493) were purchased from Procell Life Science & Technology Co., Ltd. (Wuhan, China) in February 2023.

    Techniques: In Vitro, Imaging, Migration, Expressing, Labeling, Immunofluorescence, Staining, Fluorescence